The Lynn Health Science Institute has long been considered an innovative leader in the area of clinical trials and comprehensive medical research studies. In operation since 1997, the Lynn Institute has facilities in Oklahoma City and Norman, Oklahoma, Colorado Springs and Denver, Colorado and a fifth location in Little Rock, Arkansas and two new locations in Stillwater, Oklahoma and Tulsa, Oklahoma.
Lauren Schwab is the Director of Clinical Trials for the Lynn Institute of Tulsa and holds a master’s degree from the University of Oklahoma. Schwab joined Lynn Health Science Institute in 2011, starting as a Research Assistant/Administrative Assistant, then Research Specialist in 2014, Director of Patient Recruitment & Executive Services in 2015, and Certified Clinical Research Coordinator in 2018.
The many different roles she has served in have helped her gain knowledge in all aspects of the Lynn Institute and clinical trials. As the Director, she provides leadership and oversight to support the Lynn Institute of Tulsa, responsible for staff and Principal Investigator training, study enrollment, ensuring compliance with research processes and industry guidelines, and daily operational management at the site.
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Migraines are thought to result from changes in levels of brain chemicals in regions of the brain. Often accompanied by nausea, vomiting, and extreme sensitivity to sound and light, migraine episodes can be disabling. Treatment is with over-the-counter medication or prescription drugs. If your …
Psoriasis is a chronic autoimmune condition that can affect the skin. Plaque psoriasis is a type of psoriasis that causes thick, raised, scaly patches of skin to develop. These scaly patches often form on the elbows, knees, and scalp, and they may last for weeks, months, or years and can sometimes be painful. Psoriasis can come and go but there …
Now enrolling for clinical trials.
Contact us if you are interested in more information about ongoing clinical trials.